Article
- The EMBO Journal (1998) 17, 4046 - 4055
- doi:10.1093/emboj/17.14.4046
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-
,
and 
Sonja Kampfer1, Karina Hellbert1, Andreas Villunger1, Wolfgang Doppler1, Gottfried Baier2, Hans H. Grunicke1 and Florian Überall1
- Institute of Medical Chemistry and Biochemistry and the Institute of Medical Biology, University of Innsbruck, A-6020, Innsbruck, Austria
- Human Genetics, University of Innsbruck, A-6020, Innsbruck, Austria
Correspondence to:
Florian Überall, E-mail: Florian.Ueberall@uibk.ac.at
Received 18 December 1997; Accepted 12 May 1998; Revised 12 May 1998
Abstract
The implication of protein kinase C (PKC) isoforms cPKC-
, nPKC-
, aPKC-
and aPKC-
in the transcriptional activation of a c-fos promoter-driven CAT-reporter construct by transforming Ha-Ras has been investigated. This was achieved by employing antisense constructs encoding RNA directed against isoform-specific 5' sequences of the corresponding mRNA, and expression of PKC mutants representing either kinase-defective, dominant negative, or constitutively active forms of the PKC isoforms. The data indicate that in HC11 mouse mammary epithelial cells, transforming Ha-Ras requires the activities of the three PKC isozymes: aPKC-
, nPKC-
and aPKC-
, not, however, of cPKC-
, for the transcriptional activation of c-fos. Co-expression of oncogenic Ha-Ras with combinations of kinase-defective, dominant negative and constitutively active mutants of the various PKC isozymes are in agreement with a tentative model suggesting that, in the signaling pathway from Ha-Ras to the c-fos promoter, aPKC-
acts upstream whereas aPKC-
functions downstream of nPKC-
.
Keywords:
- antisense RNA expression,
- c-fos,
- Ha-Ras,
- mitogenic signal transduction,
- protein kinase C isoenzymes



